• Earlier this month, Insperity showcased its Insperity HR360, HRCore and HRScale HR solutions at SHRM26, the major annual conference for HR professionals hosted by SHRM, highlighting how its combined service and technology offerings aim to simplify HR administration and deepen workforce insights.
• This high-visibility presence at SHRM26 underlines Insperity’s push to position its HR platforms as core tools for organizations managing workforce transformation and talent development.
• Next, we’ll examine how Insperity’s enhanced HR360, HRCore and HRScale offering at SHRM26 may influence the company’s broader investment narrative.

Find 48 companies with promising cash flow potential yet trading below their fair value.

Insperity Investment Narrative Recap

To own Insperity, you need to believe that its mix of high touch HR services and scalable technology can convert client stickiness into sustainable profitability, despite recent losses and healthcare cost pressures. The SHRM26 showcase of HR360, HRCore and HRScale supports the near term catalyst of better technology driven client engagement, but does not materially change the key risk around elevated benefits costs and tight SMB hiring weighing on margins and earnings guidance.

The most relevant recent announcement here is the general availability of HRScale, which pairs Insperity’s PEO model with Workday’s HCM and payroll tools for SMBs. SHRM26 effectively put that offering in front of a concentrated audience of HR decision makers, which may matter for how quickly HRScale ramps relative to its sizeable upfront investment and the current guidance range for 2026 profitability.

Yet against that opportunity, investors should be aware that concentration in one major benefits carrier and persistent healthcare cost pressure could...

Insperity's narrative projects $8.0 billion revenue and $94.5 million earnings by 2029.

Uncover how Insperity's forecasts yield a $40.50 fair value, a 9% upside to its current price.

Exploring Other Perspectives

While SHRM26 spotlights HRScale’s potential, the most pessimistic analysts were already assuming only about 6.8% annual revenue growth and US$95.6 million of 2028 earnings, so you should weigh whether this kind of product traction could shift those cautious expectations or reinforce concerns about slower adoption and higher platform costs.

Explore 4 other fair value estimates on Insperity - why the stock might be worth over 5x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Insperity research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Insperity research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Insperity's overall financial health at a glance.

Ready For A Different Approach?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 14 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.